Small-Molecule Modulators Targeting Toll-like Receptors for Potential Anticancer Therapeutics

Area of Science:

• Immunology
• Oncology
• Pharmacology

Background:

• Toll-like receptors (TLRs) are critical innate immune sensors linking innate and adaptive immunity.
• TLRs play a dual role in tumorigenesis, influencing both tumor immune evasion and antitumor responses via nuclear factor κ-B signaling.
• The therapeutic potential of TLRs in cancer treatment is significant, with approved drugs like imiquimod demonstrating efficacy.

Purpose of the Study:

• To summarize the structure, signaling pathways, and functions of the Toll-like receptor family.
• To discuss the structure-activity relationships of TLR modulators for selective and multitarget approaches.
• To explore the potential applications of TLR modulators in tumor therapy.

Main Methods:

• Review of existing literature on TLR structure, function, and signaling pathways.
• Analysis of structure-activity relationships for TLR agonists and antagonists.
• Systematic discussion of TLR modulators' potential in cancer treatment.

Main Results:

• TLRs exhibit complex roles in tumor immunity, capable of both promoting and inhibiting cancer progression.
• Selective and multitarget TLR modulators show promise for tailored cancer therapies.
• Understanding TLR structure-activity relationships is key to developing effective cancer drugs.

Conclusions:

• TLRs represent a significant target for cancer prevention and treatment strategies.
• TLR agonists and antagonists hold considerable potential for novel drug development in oncology.
• Further research into TLR modulators could lead to advanced tumor therapies.